5,000 breast cancer sufferers could be spared chemotherapy if offered gene testing, study suggests 


THOUSANDS of women with breast cancer could be spared chemotherapy if they were offered gene tests which show whether their disease is likely to spread, a major trial has found.

The British study suggests that up to 5,000 women a year could avoid the toxic treatment, which can cause nausea and fatigue, through wider use of genetic risk profiling.

Currently a test called Oncotype DX is offered to around 9,000 patients a year by the NHS when disease has not spread to the lymph nodes.

But the new study suggests that the tests could also be used to tailor treatment for around 10,000 patients in whom disease has progressed, identifying which cases require chemotherapy and which can be helped by hormone…


Please enter your comment!
Please enter your name here